Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $1.70

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its target price lowered by Deutsche Bank Aktiengesellschaft from $3.00 to $1.70 in a research report issued on Friday, The Fly reports. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 30.77% from the stock’s current price.

Several other analysts also recently commented on AVAH. Credit Suisse Group downgraded Aveanna Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $2.00 to $1.00 in a research note on Friday, January 27th. Royal Bank of Canada downgraded Aveanna Healthcare from an “outperform” rating to a “sector perform” rating and dropped their price objective for the stock from $7.00 to $3.00 in a research note on Monday, November 21st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $2.34.

Aveanna Healthcare Trading Down 6.5 %

Shares of Aveanna Healthcare stock opened at $1.30 on Friday. Aveanna Healthcare has a 12 month low of $0.67 and a 12 month high of $6.00. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 5.63. The stock’s fifty day simple moving average is $1.25 and its 200 day simple moving average is $1.22.

Institutional Trading of Aveanna Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of AVAH. Envestnet Asset Management Inc. increased its position in shares of Aveanna Healthcare by 15.7% in the first quarter. Envestnet Asset Management Inc. now owns 26,363 shares of the company’s stock valued at $90,000 after acquiring an additional 3,569 shares during the last quarter. Swiss National Bank increased its position in shares of Aveanna Healthcare by 7.4% in the first quarter. Swiss National Bank now owns 108,800 shares of the company’s stock valued at $371,000 after acquiring an additional 7,500 shares during the last quarter. Natixis Advisors L.P. increased its position in shares of Aveanna Healthcare by 18.0% in the first quarter. Natixis Advisors L.P. now owns 415,964 shares of the company’s stock valued at $1,419,000 after acquiring an additional 63,365 shares during the last quarter. MetLife Investment Management LLC increased its position in shares of Aveanna Healthcare by 54.9% in the first quarter. MetLife Investment Management LLC now owns 28,914 shares of the company’s stock valued at $99,000 after acquiring an additional 10,246 shares during the last quarter. Finally, BlackRock Inc. increased its position in shares of Aveanna Healthcare by 2.3% in the first quarter. BlackRock Inc. now owns 3,087,209 shares of the company’s stock valued at $10,526,000 after acquiring an additional 69,609 shares during the last quarter. Institutional investors and hedge funds own 91.65% of the company’s stock.

About Aveanna Healthcare

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.